Nucleocapsid protein of SARS-CoV activates interleukin-6 expression through cellular transcription factor NF-kappaB

Virology. 2007 Sep 1;365(2):324-35. doi: 10.1016/j.virol.2007.04.009. Epub 2007 May 9.

Abstract

High levels of interleukin-6 (IL-6) in the acute stage associated with lung lesions were found in SARS patients. To evaluate the mechanisms behind this event, we investigated the roles of SARS-CoV proteins in the regulation of IL-6. Results showed that the viral nucleocapsid (N) protein activated IL-6 expression in a concentration-dependent manner. Promoter analyses suggested that NF-kappaB binding element was required for IL-6 expression regulated by N protein. Further studies demonstrated that N protein bound directly to NF-kappaB element on the promoter. We also showed that N protein activated IL-6 expression through NF-kappaB by facilitating the translocation of NF-kappaB from cytosol to nucleus. Mutational analyses revealed that two regions of N protein were essential for its function in the activation of IL-6. These results provided new insights into understanding the mechanism involved in the function of SARS-CoV N protein and pathogenesis of the virus.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Artificial Gene Fusion
  • Cell Line
  • Cell Nucleus / chemistry
  • Coronavirus Nucleocapsid Proteins
  • Cytoplasm / chemistry
  • Electrophoretic Mobility Shift Assay
  • Epithelial Cells / virology
  • Genes, Reporter
  • Humans
  • Immunoprecipitation
  • Interleukin-6 / genetics*
  • Luciferases / analysis
  • Luciferases / genetics
  • Lung / immunology*
  • Lung / virology
  • Mutation
  • NF-kappa B / metabolism*
  • Nucleocapsid Proteins / immunology*
  • Nucleocapsid Proteins / metabolism*
  • Protein Binding
  • Protein Transport
  • Sequence Deletion
  • Severe acute respiratory syndrome-related coronavirus / immunology*

Substances

  • Coronavirus Nucleocapsid Proteins
  • Interleukin-6
  • NF-kappa B
  • Nucleocapsid Proteins
  • Luciferases